Latest
Directing the Evolution of Common Human Precursors into HIV-1 Broadly Neutralizing Antibodies
Project Summary An effective HIV vaccine will likely elicit broadly neutralizing antibodies (bnAbs). Doing so, however, remains a major challenge because bnAbs usually require multiple rare and unusual changes that emerge after years of active infection. It is not clear that a practical number of immunizations can consistently recapitulate this process. Although investigators have successfully expanded defined precursors of known bnAbs, they have not moved these diversified precursors to a specific target in humans. Importantly here, the severity of this problem increases rapidly with the number changes needed. The problem further deepens if the required changes are in slow-to-mutate antibody framework regions or require specific indels. The need to move from precursor to bnAb in the fewest steps motivates our focus on the V2 apex epitope of the HIV-1 envelope glycoprotein (Env). Apex bnAbs are qualitatively different from other bnAb classes. They require far fewer mutations, located in their rapidly evolving heavy-chain CDR3 (HCDR3) regions. These HCDR3s are unusually important to their ability to neutralize virus. For example, we have shown that a diverse repertoire of mouse B cell receptors can be modified with apex bnAb HCDR3s, and the resulting mouse B cells generated potent neutralizing sera. Thus, apex precursors can largely be defined by their HCDR3s alone and are far more common than other defined bnAb precursors. Interestingly, these HCDR3 are very similar to those of another class of antibodies that recognize the CD4-induced co-receptor-binding site (CoRBS). Both antibody classes have unusually long HCDR3s with sulfated tyrosines at their tips. Unlike apex bnAbs, these non-neutralizing CoRBS antibodies are readily elicited through vaccination. We have recently shown that apex precursors also bind the CoRBS, suggesting that some apex bnAbs emerge from CoRBS antibodies. Thus, the first step of sequential vaccine strategies, expanding and diversifying a defined precursor pool, is straightforward. Here we divide the remaining goals into two: moving from a precursor that does not bind Env to one that does so and then broaden it to recognize the majority of circulating isolates. We have already made significant progress in the first step: we have shown in our original mouse vaccine model that we can generate potent apex- specific neutralizing antisera. However the breadth of this sera remains limited. Building on these studies, we will pursue three goals: (1) Define the essential mutations that transform a CoRBS antibody into one that binds the Env apex and then generate antigens that select for these mutations. (2) Define mutations and generate antigens that expand the breadth of these antibodies, transforming them to bnAbs, and (3) Evaluate these antigens in a novel system that models key features of the human apex response in mice, and iteratively refine this process using antibodies and HCDR3s drawn from a wide panel of HIV-naïve persons. In short, these studies develop original concepts and tools that can accelerate development of an HIV-1 vaccine and deepen our understanding of the antibody response to vaccines and pathogens.
Careers for neuroscience in Artificial Intelligence
The purpose of this event is twofold: to raise awareness of careers in AI to neuroscience postgraduate and Early Career Researchers (ECRs), and to give the chance for commercial organisations to acquire and diversify their talent pool. We know that our early career members are highly motivated and interested in different career pathways, and wish to help them fulfil their ambitions. This will be a hybrid event held in person at Arca Blanca, Covent Garden, London and also available online. FREE for BNA members!
How evidence synthesis can boost in vivo credibility
As part of the BNA's ongoing Credibility in Neuroscience work, this series of three short webinars will provide neuroscience researchers working in an in vivo setting with tips on how to improve the credibility of their work. Each webinar will be hosted by Emily Sena, member of the BNA's Credibility Advisory Board, with the opportunity for questions.
Embracing variation to boost reproducibility
As part of the BNA's ongoing Credibility in Neuroscience work, this series of three short webinars will provide neuroscience researchers working in an in vivo setting with tips on how to improve the credibility of their work. Each webinar will be hosted by Emily Sena, member of the BNA's Credibility Advisory Board, with the opportunity for questions.
Improving reliability through design and reporting
As part of the BNA's ongoing Credibility in Neuroscience work, this series of three short webinars will provide neuroscience researchers working in an in vivo setting with tips on how to improve the credibility of their work. Each webinar will be hosted by Emily Sena, member of the BNA's Credibility Advisory Board, with the opportunity for questions.
Careers in neuroscience (and beyond!)
Join us to hear about degrees and careers in neuroscience, what it’s like to be a neuroscientist, the wide range of career options open to you after a neuroscience degree, first-hand examples of career paths in neuroscience, and some tips and thoughts to help you in your own careers. This free and friendly webinar will give you the chance to ask questions from people with different experiences in neuroscience: - Emma Soopramanien, the BNA Committee Representative for Students and Early Career Researchers – Emma has just completed her undergraduate course in neuroscience, and will be hosting the webinar. - Professor Anthony Isles, BNA Trustee – Anthony is a professor at Cardiff University, where he researches epigenetic mechanisms of brain and behaviour and how they contribute to neurodevelopmental and neuropsychiatric disorders, as well as teaching undergraduate and postgraduate students. He will talk about how he came to be a neuroscientist researcher and ways into neuroscience. - Dr Anne Cooke, BNA Chief Executive – Anne studied physiology and neuroscience at university and carried out research into neuronal communication, before then following a career path with roles in academia and industry, and now as CE at the BNA. Anne will describe her own career in neuroscience, as well as some of the many other options open to you after a neuroscience degree.
British Neuroscience Association (BNA) Festival - 2021
In April 2021, in partnership with the UK Dementia Research Institute, the British Neuroscience Association will host its fifth Festival of Neuroscience. Due to the ongoing uncertainty around COVID19, our 2021 event will be the first ever online Festival of Neuroscience. Although we are sorry to miss meeting in person, we're excited to create a whole new Festival experience! The ambition and scope of the BNA Festivals make them unparalleled across neuroscience. Being online will not change how the BNA2021 event will: - bring together multiple organisations with an interest in brain research at a single, shared event, creating a novel, multi-organisation forum featuring all areas of fundamental research in neuroscience and psychology, from both academia and the commercial sector, plus clinical expertise in neurology and psychiatry. - include a programme of public events as well. Past Festivals have seen a rap performance about consciousness, lunchtime talks, sessions in schools, and much more.
BNA coverage
7 items
Add content
Have a seminar, talk, or paper on BNA? Post it so others working in this area can find it.
Post content